WASHINGTON - The U.S. Drug Enforcement Administration has launched a new tool to assist drug manufacturers and distributors with their regulatory obligations under the Controlled Substances Act. This new resource is an example of the many ways DEA is working collaboratively with its 1.73 million registrants to combat the ongoing...

WASHINGTON - The U.S. Drug Enforcement Administration this week placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule I-the category for substances with no currently accepted medical use-for two years, with the possibility of a one-year extension. This action is expected to reduce these...

LUBBOCK, Texas - Gregory Jerome Mitchell, a.k.a “Jimmy Jombo Kalu,” 33, was sentenced on January 19, 2018 by Senior U.S. District Judge Sam R. Cummings to 262 months in federal prison for distributing cocaine, announced Special Agent-in-Charge Clyde E. Shelley, Jr. of the DEA and U.S. Attorney Erin Nealy Cox...

WASHINGTON - Attorney General Jeff Sessions travelled to the FBI Academy on Marine Corps Base Quantico, Virginia, on Friday, January 26, 2018, to deliver remarks to graduates of the Drug Enforcement Administration Basic Agent Trainee class. Attorney General Sessions was hosted by DEA’s Acting Administrator Robert Patterson and Training Division...

WASHINGTON - The United States Drug Enforcement Administration today announced a deregulatory measure that will make it easier for residents of underserved areas to receive treatment for opioid addiction. As published today in the Federal Register, nurse practitioners and physician assistants can now become DATA-Waived qualifying practitioners, which gives them...

WASHINGTON - A member of the Honduran National Congress faces U.S. charges for drug trafficking, weapons and conspiracy thanks to a DEA-led international drug investigation, federal law enforcement officials announced today. Honduran Congressman Fredy Renan Najera Montoya has been charged in Manhattan federal court with conspiring to import cocaine into...

WASHINGTON - The Drug Enforcement Administration is streamlining the application process for researchers who study or wish to study Schedule I substances not currently approved for medical use. Schedule I drugs are defined as drugs, substances, or chemicals with no accepted medical use and a high potential for abuse, such...

WASHINGTON - China’s Ministry of Public Security last week announced scheduling controls on two fentanyl precursor chemicals - NPP and 4ANPP, substances that can be used to make illicit drugs. The scheduling controls will take effect on February 1, 2018 and is the result of the ongoing collaboration between the...

WASHINGTON - Joon H. Kim, the Acting United States Attorney for the Southern District of New York, and Raymond Donovan, the Special Agent-in-Charge of the Drug Enforcement Administration’s Special Operations Division, announced today that Efrain Antonio Campo (“Campo Flores”) and Franqui Francisco Flores De (“Flores De Freitas”) were each sentenced...

WASHINGTON - The Drug Enforcement Administration’s Los Angeles Field Division today announced Operation Faux Pharmacy, a multi-pronged initiative aimed at attacking the opioid epidemic by targeting rogue pharmacies throughout southern California, Hawaii and Nevada. DEA investigations over the last year identified as many as 26 pharmacies in these areas that...